ACHE and early-onset autosomal dominant Alzheimer disease: Furthermore, studies have shown that bioactive compounds in F. fomentarius can reduce AChE activity, suggesting its potential as a neuroprotective agent in conditions such as Alzheimer’s disease [3,23].